Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million
Go back to Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million| (NASDAQ: SYRE) | Delayed: 96.01 -4.31 (4.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.32 | 52 Week High | $ | |||
| Open | $97.72 | 52 Week Low | $ | |||
| Day High | $102.06 | P/E | N/A | |||
| Day Low | $95.31 | EPS | $ | |||
| Volume | 1,761,953 | |||||
